Sáez-Valero J - Search Results

1

Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease.

Sáez-Valero J, Sberna G, McLean CA, Masters CL, Small DH. Sáez-Valero J, et al. Lancet. 1997 Sep 27;350(9082):929. doi: 10.1016/S0140-6736(97)24039-0. Lancet. 1997. PMID: 9314873 No abstract available.

2

The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells.

Sberna G, Sáez-Valero J, Beyreuther K, Masters CL, Small DH. Sberna G, et al. J Neurochem. 1997 Sep;69(3):1177-84. doi: 10.1046/j.1471-4159.1997.69031177.x. J Neurochem. 1997. PMID: 9282941 Free article.

3

Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.

Sberna G, Sáez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, McLean CA, Small DH. Sberna G, et al. J Neurochem. 1998 Aug;71(2):723-31. doi: 10.1046/j.1471-4159.1998.71020723.x. J Neurochem. 1998. PMID: 9681463 Free article.

4

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

Sáez-Valero J, Sberna G, McLean CA, Small DH. Sáez-Valero J, et al. J Neurochem. 1999 Apr;72(4):1600-8. doi: 10.1046/j.1471-4159.1999.721600.x. J Neurochem. 1999. PMID: 10098867 Free article.

5

Inhibition of neurite outgrowth from chick sympathetic neurons by cholinesterase inhibitors is not mediated by binding to cholinesterases.

Postuma RB, Sáez-Valero J, Small DH. Postuma RB, et al. Neurosci Lett. 1999 May 7;266(2):77-80. doi: 10.1016/s0304-3940(99)00266-9. Neurosci Lett. 1999. PMID: 10353331

6

Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Sáez-Valero J, et al. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):664-7. doi: 10.1136/jnnp.69.5.664. J Neurol Neurosurg Psychiatry. 2000. PMID: 11032625 Free PMC article.

7

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

Sáez-Valero J, Small DH. Sáez-Valero J, et al. Brain Res. 2001 Jan 19;889(1-2):247-50. doi: 10.1016/s0006-8993(00)03144-9. Brain Res. 2001. PMID: 11166713

8

An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease.

Sáez-Valero J, Mok SS, Small DH. Sáez-Valero J, et al. Acta Neurol Scand Suppl. 2000;176:49-52. doi: 10.1034/j.1600-0404.2000.00307.x. Acta Neurol Scand Suppl. 2000. PMID: 11261805

9

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.

Fodero LR, Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Fodero LR, et al. J Neurochem. 2001 Dec;79(5):1022-6. doi: 10.1046/j.1471-4159.2001.00640.x. J Neurochem. 2001. PMID: 11739614 Free article. Clinical Trial.

10

Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.

Sáez-Valero J, de Ceballos ML, Small DH, de Felipe C. Sáez-Valero J, et al. Neurosci Lett. 2002 Jun 14;325(3):199-202. doi: 10.1016/s0304-3940(02)00282-3. Neurosci Lett. 2002. PMID: 12044655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters